Bharat Bio successfully completes Phase III trials of new oral...

Dununu.com Dununu

Commandité

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National

Posté

147

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Connectez-vous pour aimer, partager et commenter!

'We defend Raavana for the first time': Raj on Yash's Ramayana

Nitesh Tiwari’s ambitious project Ramayana has been making waves in the entertainment...

Par 0 10

7 Emirates, 7 Thrones: A look inside UAE’s Ruling Families

The United Arab Emirates comprises seven emirates, each ruled by its own royal family. These...

Par 0 10

New visa rules in Saudi Arabia: Here's everything expats need to know

Saudi Arabia's new skill-based visa system, effective July 2025, categorizes expats into...

Par 0 10

Who are Yemen’s Houthis, the group behind the recent Red Sea cargo ship attack?

Yemen’s Houthi rebels struck the cargo ship Magic Seas in the Red Sea, marking their first...

Par 0 10

'He died trying to save village': Eyewitness recalls scattered remains, a diary, and a pilot's last act of bravery during fighter jet crash

Par 0 14